HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Gynecological Pathology"
DOI: 10.1097/pgp.0000000000000711
Abstract: Anti-HER2 therapy has recently emerged as an effective targeted treatment approach for patients with advanced stage and recurrent endometrial serous carcinoma, resulting in significantly prolonged progression-free and overall survival when combined with the standard chemotherapy… read more here.
Keywords: her2 testing; serous carcinoma; pathology; carcinoma ... See more keywords
Endometrial Serous Carcinoma With Clear-Cell Change: Frequency and Immunohistochemical Analysis
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Surgical Pathology"
DOI: 10.1177/1066896917731862
Abstract: The diagnostic distinction between endometrial serous carcinoma (ESC) and endometrial clear-cell carcinoma (CCC) may occasionally be problematic, and one potentially contributing factor is the finding of clear cells in otherwise classic cases of ESC. This… read more here.
Keywords: group; endometrial serous; serous carcinoma; clear cells ... See more keywords